Printer Friendly
The Free Library
14,558,366 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for Erimos Pharmaceuticals.


Founded in 2000, Erimos Pharmaceuticals is focused on the discovery, development and commercialization of small molecule therapeutics to treat cancer, HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  and autoimmune diseases Autoimmune diseases
A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs.

Mentioned in: Complement Deficiencies, Premature Menopause
. The products in development are drawn from a novel class of drugs preventing tumor cell replication and promoting selective tumor cell death, or apoptosis.

Historically, chemicals found in certain plants around the world have been known to be beneficial in treating certain diseases. Erimos has exclusive license for nordihydroguaiaretic acid nordihydroguaiaretic acid

one of a group of chemicals which cause renal cysts when administered to experimental animals.
 (NDGA NDGA Nordihydroguaiaretic Acid
NDGA Nigerian Dwarf Goat Association
NDGA National Depression Glass Association
NDGA North Dakota Geographic Alliance
NDGA No Degree, Good Anyway
) derivatives from The Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. . NDGA is found in the resin of the leaves of a desert plant, Larrea tridentata Larrea tridentata,
n See chaparral.
. Erimos' synthetic derivative is designed to address specific differences between normal human cells and those cells that are abnormally aggressively dividing, and to target abnormal tumor cells while causing little or no toxicity to healthy cells.

Erimos is headquartered in Houston, Texas, with primary Research and Development offices and laboratory facilities in Raleigh, North Carolina For other uses of this name, see Raleigh.
Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County.
.
Company:                Erimos Pharmaceuticals

   Headquarters Address:   930 Main Campus Drive
                           Suite 100
                           Raleigh, NC 27606

   Main Telephone:         919-821-5204

   Type of Organization:   Private

   Industry:               Health: Pharmaceutical

   Key Executives:         CEO: Jeff Khoo
                           COO: Neil Frazer
                           VP, Commercial: Jean Chitwood

   COO
     Contact:              Neil Frazer
     Phone:                919-821-5204x2803
     Email:                nfrazer@erimos.com

   VP, Commercial
     Contact:              Jean Chitwood
     Phone:                919-821-5204x2806
     Email:                jchitwood@erimos.com

   Public Relations
     Contact:              Nancy Wiersma
     Phone:                919-821-5204x2815
     Email:                nwiersma@erimos.com
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company Profile
Date:Mar 17, 2006
Words:219
Previous Article:Company Profile for Vestal.(Company Profile)
Next Article:Company Profile for SalesBuilder, Inc.(Company Profile)
Topics:



Related Articles
VALIGEN ACQUIRES BERLIN-BASED INFOGEN AND PHENOTYPE DATABASE.
LION GETS NEW AND UPGRADED LICENSES FOR SRS.
See New Profiles of the 100 Major Pharmaceutical Companies in India.
Company Profile for Valeant Pharmaceuticals International.(Company Profile)
Triangle Science Collaboration Could Impact Influenza, Avian Flu Treatment; NC State, Erimos Pharmaceuticals File Patent for Joint Efforts.
Erimos Pharmaceuticals Announces Phase I Study of EM-1421 Initiated at Three U.S. Sites; Intravenous formulation to target tumors unresponsive to...
Piribo: Trends in the Global Pharma Market until 2010 Now Available.(Industry overview)
Erimos Pharmaceuticals Announces Phase I/Phase II Study of Terameprocol (EM-1421) In Conjunction with New Approaches to Brain Tumor Therapy (NABTT)...
Research and Markets: Real-World Examples Show How Great Companies, Such as Allergan, Genentech, Pfizer and Wyeth, Allocate Resources Throughout the...
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles